NCT01806662View on ClinicalTrials.gov

Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Atopic Dermatitis
Interventions
DRUG

Ustekinumab

Injection of monoclonal antibody against the p40 subunit of IL-12/23

OTHER

Placebo

Injection of placebo

Trial Locations (1)

10065

Rockefeller University, New York

All Listed Sponsors
lead

Rockefeller University

OTHER

NCT01806662 - Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis | Biotech Hunter | Biotech Hunter